Moderna vaccine sales treble in first quarter

COVID-19 mRNA vaccine sends income and profits through the roof Vaccine sales for US biotech company Moderna were three times what they were for the same period last year, according to the company's just published first quarter 2022 results. This led the company, whose mRNA COVID-19 vaccine Spikevax was distributed exclusively by pharmacies on Australian